YAP1 and melanoma: Cell‐autonomous ECM deposition and remodeling abilities adopted by melanoma cells after MAPKi treatment result in cross‐linked collagen matrix and tumor stiffening fostering a feedforward loop dependent on the mechanotransducers YAP and MRTFA and leading to therapy resistance (Girard et al, 2020).